role of antioxidants in the treatment of oral submucous fibrosis: a clinical and histopathological study
Clicks: 144
ID: 166601
2009
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Background: With the increased incidence of oral submucous fibrosis and treatment being not completely satisfactory, the need for alternative method of treatment is increasing. The present study evaluates the efficacy of oral antioxidant preparations in the treatment of clinically and histopathologically proved oral submucous fibrosis. Methods: Study was conducted in 40 patients of two groups of all ages who were clinically and histopathologically proved with oral submucous fibrosis with standard data grading and biopsies before and after the study for evaluation. Results: On comparison with the control group of placebo treatment, antioxidant therapy has shown a significant improvement (i e 70ā²0 P < 0.001 for interincisal distance: P < 0.001 for tongue protrusion and P < 0.05 for blowing capacity) and moderate improvement in histopathological findings of the treatment group. Conclusions: Significant number of cases have shown increased mouth opening, tongue protrusion. and blowing capacity and decreased burning sensation after treatment with antioxidants. Histopathologically, there is a certain amount of improvement, but not proportional with clinical improvement which shows that antioxidants can be useful therapeutic adjuvants to the already available treatment modalities in oral submucous fibrosis.Reference Key |
kumar2009journalrole
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | ;B Vijay Kumar |
Journal | history of psychiatry |
Year | 2009 |
DOI | DOI not found |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.